Ancora Advisors’s Aimmune Therapeutics AIMT Stock Holding History

Ancora Advisors’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,253	Closed	-$43K	–	1584
2020 Q3	$43K	Buy	+1,253	New	+$26.7K	﹤0.01%	887

Ancora Advisors's AIMT Position: Q4 2020 in Review

Ancora Advisors sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 1,253 shares — an estimated $43K sold.

Ancora Advisors first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $43K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Ancora Advisors reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Ancora Advisors sold 1,253 Aimmune Therapeutics shares in Q4 2020, an estimated $43K.
Ancora Advisors first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Ancora Advisors's Aimmune Therapeutics position peaked at $43K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Ancora Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.